COVID vaccine supply for global programme outstrips demand for first time
As supply and donations have ramped up, poorer nations are facing hurdles such as gaps in cold-chain shortage, vaccine hesitancy…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
COVID-19 Updates
We are making a ‘pancorona virus’ vaccine that will protect against all coronavirus variants: Dr…
During BioAsia 2022, Genome Valley Excellence Award recipient, Dr Weissman talked about mutations, mRNA technology, new vaccines…
COVID vaccine doesn’t raise risk of rare inflammation in children: Lancet
The reporting rate of MIS-C for those without evidence of SARS-CoV-2 infection was 0.3 cases per million vaccinated individuals
WHO establishes global biomanufacturing training hub in Republic of Korea
Bangladesh, Indonesia, Pakistan, Serbia and Vietnam to receive mRNA technology from the technology transfer hub
Sanofi and GSK to seek regulatory authorisation for COVID-19 vaccine
Final analysis of the global VAT02 booster trial confirms universal ability to boost neutralising antibodies 18-to 30-fold across…
Probiotic capsules may speed up COVID recovery, says study
Probiotics are over-the-counter tablets and drinks said to bolster the gut microbiome, the complex intestinal 'soup' made up of…
‘TRIPS Waiver’ must be agreed now, says MSF
Access needs to be ensured for not just COVID-19 vaccines, but all COVID-19 medical tools, for everyone, everywhere
Covaxin to be evaluated as COVID-19 vaccine candidate in US as US FDA lifts clinical hold
Ocugen Inc is co-developing the Covaxin vaccine candidate for COVID-19 in the US and Canada
Valneva receives 12.5 million pound COVID-19 vaccine manufacturing grant in Scotland
Valneva will receive the funds from Scotland's national economic development agency Scottish Enterprise, which it has been in…
COVID-19 vaccine from Biological E.,CORBEVAX gets EUA from DCGI for 12-18 age group
DCGI has already approved CORBEVAX for restricted use in emergency situation among adults
CEPI, THSTI and Panacea Biotec partner to develop betacoronavirus vaccines
Under the terms of the funding agreement, THSTI and Panacea Biotec have committed to achieve equitable access to the outputs of…
Movfor phase-III trials show positive results: Hetero
Early viral clearance (negative RT-PCR) and significant clinical improvement were observed within five days of administering the…
Quality of antibodies improves for months after COVID vaccination: Study
The researchers at Washington University School of Medicine in the US assessed the antibody response to the Pfizer-BioNTech…
EU to donate 29 million COVID vaccine doses to Africa
Germany will contribute 21 million vaccine doses, a government official said ahead of the meeting between leaders of the African…
Rovi seals 10-year Moderna deal extension to manufacture mRNA drugs
The deal includes new investment to expand capacity at Rovi’s plants, the company said without disclosing the amount of investment
Study finds three doses of Pfizer COVID vaccine better than two
The study, published in The Lancet Regional Health-Americas, assessed the effectiveness of two doses of the Pfizer COVID-19…
Israel to offer AstraZeneca’s Evusheld to immunocompromised people
Evusheld has been approved by the US FDA and has proven to be 83 per cent effective in preventing serious illness and death from…
China’s potential mRNA COVID vaccine weaker against Omicron: Study
The vaccine is being tested in an international phase-III clinical trial
Five-day course of Molnupiravir effective and safe for non-pregnant and unvaccinated COVID-19 adult…
The study has been conducted jointly by Fortis C-DOC, G D Hospital and Diabetes Institute, Jawaharlal Nehru Medical College and…